KYANâs mission is to BRIDGE THE CANCER CARE GAP by advancing revolutionary technologies
Location: Singapore
Employees: 11-50
Founded date: 2016
Investors 1
| Date | Name | Website |
| 31.01.2023 | Altara Ven... | altaravent... |
Mentions in press and media 4
| Date | Title | Description |
| 24.03.2025 | Study Validates Effectiveness of KYAN Tech's Platform for Combination Therapy Prediction and Target Discovery in Sarcoma | Groundbreaking study published in npj Precision Oncology highlights Optim.AI’s potential to revolutionize personalized cancer treatment strategies SINGAPORE, SINGAPORE, March 24, 2025 /EINPresswire.com/ -- KYAN Technologies Pte. Ltd. (“KYAN... |
| 20.02.2025 | KYAN Technologies to Present Lymphoma Immunotherapy Response Data for Predictive Platform at 2025 AACR IO Conference | SINGAPORE, SINGAPORE, February 20, 2025 /EINPresswire.com/ -- KYAN Technologies Pte. Ltd. (“KYAN”), a functional precision medicine focused company, today announced a poster presentation at the 2025 American Association for Cancer Research ... |
| 05.12.2024 | KYAN Technologies to Present Predictive Cancer Response Test Immunotherapy Data at the 66th ASH Annual Meeting | SINGAPORE, SINGAPORE, December 4, 2024 /EINPresswire.com/ -- KYAN Technologies Pte. Ltd. (“KYAN”), a biotech company that has developed clinically utilized functional precision medicine technology, today announced a poster presentation at t... |
| 29.05.2023 | KYAN Technologies obtains MOH approval in Singapore and will offer OPTIM.AI™ for cancer patients | OPTIM.AI™ is a Functional Precision Medicine Test that supports physicians to personalize treatments SINGAPORE, May 29, 2023/EINPresswire.com/ -- KYAN Technologies Pte Ltd, a leading biotechnology company headquartered in Singapore, is prou... |